Skip to content
10-Q

Quarterly Report

CANCER CAPITAL CORP.

0001554795-22-000184

← back to feed
Filed
May 13, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 13, 2022 6.15M sh
Cash And Equivalents Q1 2022 · Mar 31, 2022 $20.45K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $62
Cash And Equivalents Q1 2022 · Mar 31, 2021 $698
Cash And Equivalents Q1 2022 · Dec 31, 2020 $698
Current Liabilities Q1 2022 · Mar 31, 2022 $403.78K
Current Liabilities Q1 2022 · Dec 31, 2021 $369.19K
Total Liabilities Q1 2022 · Mar 31, 2022 $403.78K
Total Liabilities Q1 2022 · Dec 31, 2021 $369.19K
Current Assets Q1 2022 · Mar 31, 2022 $20.45K
Current Assets Q1 2022 · Dec 31, 2021 $62
Total Assets Q1 2022 · Mar 31, 2022 $20.45K
Total Assets Q1 2022 · Dec 31, 2021 $62
Stockholders Equity Q1 2022 · Mar 31, 2021 −$342.23K
Stockholders Equity Q1 2022 · Dec 31, 2020 −$332.34K
Sga Expense Q1 2022 · Mar 31, 2021 $5.4K
Net Income Q1 2022 · Mar 31, 2021 −$9.89K
Operating Income Q1 2022 · Mar 31, 2021 −$5.4K